Company intelligence
BioCurie
Re-imagining Genomic Medicine — for AIl
Biotechnology Research
12 employees
Founded 2021
5 public signals
About BioCurie
Intelligent software for transforming the development and manufacturing of cell, gene, and RNA therapies.
Verified activity
Signals from BioCurie
5 published signals
People
BioCurie promoted Francesco Destro to Chief Technology Officer.
Reported by BioCurie
People
BioCurie promoted Francesco Destro to Chief Technology Officer.
Reported by Irene Rombel
Capital & Finance
BioCurie is funded by the Advanced Research Projects Agency for Health to advance US scientific breakthroughs into safe, effective medicines that can be manufactured reproducibly and affordably.
Reported by Irene Rombel
Presence & Recognition
BioCurie employee Irene Rombel is joining the Advanced Therapies Think Tank as an expert guest for the first live discussion of Season 2.
Reported by Irene Rombel
Presence & Recognition
BioCurie Founder and CEO Dr. Irene Rombel will join the Advanced Therapies Think Tank - AT3 for the first live discussion of Season 2 on September 3.
Reported by BioCurie